Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 02, 2021

Genetic Identification of Older Patients With AML Achieving Long-Term Survival With Intensive Chemotherapy



Additional Info

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy
Blood 2021 Aug 19;138(7)507-519, R Itzykson, E Fournier, C Berthon, C Röllig, T Braun, A Marceau-Renaut, C Pautas, O Nibourel, E Lemasle, JB Micol, L Adès, D Lebon, JV Malfuson, L Gastaud, L Goursaud, E Raffoux, KJ Wattebled, P Rousselot, X Thomas, S Chantepie, T Cluzeau, H Serve, N Boissel, C Terré, K Celli-Lebras, C Preudhomme, C Thiede, H Dombret, C Gardin, N Duployez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading